-
2
-
-
0029898333
-
Mechanisms of preferential metastasis of breast cancer to bone
-
Yoneda, T. Mechanisms of preferential metastasis of breast cancer to bone. Int. J. Oncol., 9: 103-109, 1996.
-
(1996)
Int. J. Oncol.
, vol.9
, pp. 103-109
-
-
Yoneda, T.1
-
3
-
-
0029884643
-
Bisphosphonates: Mechanisms of action
-
Rodan, G. R., and Fleisch, H. Bisphosphonates: mechanisms of action. J. Clin. Invest., 97: 2692-2696, 1996.
-
(1996)
J. Clin. Invest.
, vol.97
, pp. 2692-2696
-
-
Rodan, G.R.1
Fleisch, H.2
-
4
-
-
10544228130
-
Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases
-
Hortobagyi, G. N., Theriault, R. L., Porter, L., Blayney, D., Lipton, A., Sinoff, C., Wheeler, H., Simeone, J. F., Seaman, J., Knight, R. D., Heffernan, M., and Reitsma, D. J. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. N. Engl. J. Med., 335: 1785-1791, 1996.
-
(1996)
N. Engl. J. Med.
, vol.335
, pp. 1785-1791
-
-
Hortobagyi, G.N.1
Theriault, R.L.2
Porter, L.3
Blayney, D.4
Lipton, A.5
Sinoff, C.6
Wheeler, H.7
Simeone, J.F.8
Seaman, J.9
Knight, R.D.10
Heffernan, M.11
Reitsma, D.J.12
-
5
-
-
0030474026
-
Clodronate decreases the frequency of skeletal metastases in women with breast cancer
-
Kanis, J. A., Powles, T., Paterson, A. H. G., McCloskey, E. V., and Ashley, S. Clodronate decreases the frequency of skeletal metastases in women with breast cancer. Bone, 19: 663-667, 1996.
-
(1996)
Bone
, vol.19
, pp. 663-667
-
-
Kanis, J.A.1
Powles, T.2
Paterson, A.H.G.3
McCloskey, E.V.4
Ashley, S.5
-
6
-
-
0029101805
-
Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice
-
Sasaki, A., Boyce, B. F., Story, B., Wright, K. R., Chapman, M., Boyce, R., Mundy, G. R., and Yoneda, T. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res., 55: 3551-3557, 1995.
-
(1995)
Cancer Res.
, vol.55
, pp. 3551-3557
-
-
Sasaki, A.1
Boyce, B.F.2
Story, B.3
Wright, K.R.4
Chapman, M.5
Boyce, R.6
Mundy, G.R.7
Yoneda, T.8
-
7
-
-
0029916052
-
Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro
-
van der Pluijm, G., Vloedgraven, H., van Beek, E., van der Wee-Pals, L., Löwik, C., and Papapoulos, S. Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro. J. Clin. Invest., 98: 698-705, 1996.
-
(1996)
J. Clin. Invest.
, vol.98
, pp. 698-705
-
-
Van Der Pluijm, G.1
Vloedgraven, H.2
Van Beek, E.3
Van Der Wee-Pals, L.4
Löwik, C.5
Papapoulos, S.6
-
8
-
-
0001265235
-
Adjuvant treatment of breast cancer patients with the bisphosphonate clodronate reduces the incidence and number of bone and non-bone metastases
-
Diel, I. J., Solomayer, E. F., Goerner, R., Gollan, C., Wallviener, D., and Bastea, G. Adjuvant treatment of breast cancer patients with the bisphosphonate clodronate reduces the incidence and number of bone and non-bone metastases. Proc. Am. Soc. Clin. Oncol., 16: 130a, 1997.
-
(1997)
Proc. Am. Soc. Clin. Oncol.
, vol.16
-
-
Diel, I.J.1
Solomayer, E.F.2
Goerner, R.3
Gollan, C.4
Wallviener, D.5
Bastea, G.6
-
9
-
-
0024335975
-
Thrombospondin is synthesized and secreted by human osteoblasts and osteosarcoma cells
-
Clezardin, P., Jouishomme, H., Chavassieux, P., and Marie, P. J. Thrombospondin is synthesized and secreted by human osteoblasts and osteosarcoma cells. Eur. J. Biochem., 181: 721-726, 1989.
-
(1989)
Eur. J. Biochem.
, vol.181
, pp. 721-726
-
-
Clezardin, P.1
Jouishomme, H.2
Chavassieux, P.3
Marie, P.J.4
-
10
-
-
0025914766
-
Thrombospondin binds to the surface of osteosarcoma cells and mediates platelet-osteosarcoma cell interaction
-
Clezardin, P., Serre, C. M., Trzeciak, M. C., Drouin, J., and Delmas, P. D. Thrombospondin binds to the surface of osteosarcoma cells and mediates platelet-osteosarcoma cell interaction. Cancer Res., 51: 2621-2627, 1991.
-
(1991)
Cancer Res.
, vol.51
, pp. 2621-2627
-
-
Clezardin, P.1
Serre, C.M.2
Trzeciak, M.C.3
Drouin, J.4
Delmas, P.D.5
-
11
-
-
0029124093
-
Extracellular matrix synthesized by clonal osteogenic cells is osteoinductive in vivo and in vitro: Role of transforming growth factor-β in osteoblast cell-matrix interaction
-
Kirk, M., and Kahn, A. Extracellular matrix synthesized by clonal osteogenic cells is osteoinductive in vivo and in vitro: role of transforming growth factor-β in osteoblast cell-matrix interaction. J. Bone Miner. Res., 10: 1203-1208, 1995.
-
(1995)
J. Bone Miner. Res.
, vol.10
, pp. 1203-1208
-
-
Kirk, M.1
Kahn, A.2
-
12
-
-
0027527272
-
The growth-supportive effect of thrombospondin (TSP1) and the expression of TSP1 by human MG-63 osteoblastic cells are both inhibited by dexamethasone
-
Abbadia, Z., Amiral, J., Trzeciak, M. C., Delmas, P. D., and Clezardin, P. The growth-supportive effect of thrombospondin (TSP1) and the expression of TSP1 by human MG-63 osteoblastic cells are both inhibited by dexamethasone. FEBS Lett., 335: 161-166, 1993.
-
(1993)
FEBS Lett.
, vol.335
, pp. 161-166
-
-
Abbadia, Z.1
Amiral, J.2
Trzeciak, M.C.3
Delmas, P.D.4
Clezardin, P.5
-
13
-
-
0028142840
-
Integrin-ligand interactions: A year in review
-
Haas, T. A., and Plow, E. F. Integrin-ligand interactions: a year in review. Curr. Opin. Cell Biol., 6: 656-662, 1994.
-
(1994)
Curr. Opin. Cell Biol.
, vol.6
, pp. 656-662
-
-
Haas, T.A.1
Plow, E.F.2
-
14
-
-
0001146570
-
Bisphosphonate antiresorptive structure-activity relationships
-
O. Bijvoet, H. A. Fleisch, R. E. Canfield, and G. Russell (eds.), Amsterdam: Elsevier Science B.V.
-
Ebetino, F. H., and Dansereau, S. M. Bisphosphonate antiresorptive structure-activity relationships. In: O. Bijvoet, H. A. Fleisch, R. E. Canfield, and G. Russell (eds.), Bisphosphonates on bones, pp. 139-153. Amsterdam: Elsevier Science B.V., 1995.
-
(1995)
Bisphosphonates on Bones
, pp. 139-153
-
-
Ebetino, F.H.1
Dansereau, S.M.2
|